🔎 Trials Near Me

Home › Neuroblastoma › Alabama › Birmingham

Neuroblastoma clinical trials in Birmingham, AL

8 studies for Neuroblastoma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RecruitingPhase 3
  • Children's Hospital of Alabama, Birmingham
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

RecruitingPhase 2
  • University of Alabama/Children's of Alabama, Birmingham
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

RecruitingPhase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

RecruitingPhase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RecruitingPhase 3
  • Children's Hospital of Alabama, Birmingham
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

RecruitingPhase 2
  • University of Alabama/Children's of Alabama, Birmingham
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RecruitingPhase 2
  • Children's Hospital of Alabama/UAB, Birmingham
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975

About Neuroblastoma

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

More about Neuroblastoma on MedlinePlus

Neuroblastoma trials in other cities

Other studies in Birmingham

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.